| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10067-016-3295-9 |
| P698 | PubMed publication ID | 27156076 |
| P50 | author | Francesco Caso | Q30505843 |
| Matteo Megna | Q59662710 | ||
| Maddalena Napolitano | Q60322576 | ||
| Luisa Costa | Q42873474 | ||
| Raffaele Scarpa | Q57047962 | ||
| P2093 | author name string | Nicola Balato | |
| Angela Patrì | |||
| P2860 | cites work | Clinical and radiological changes during psoriatic arthritis disease progression | Q73363285 |
| Joint symmetry in early and late rheumatoid and psoriatic arthritis: comparison with a mathematical model | Q73678551 | ||
| A classification study of clinical subsets in an inception cohort of early psoriatic peripheral arthritis--'DIP or not DIP revisited' | Q73683063 | ||
| Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms | Q73797360 | ||
| Clinical and genetic aspects of psoriatic arthritis "sine psoriasis" | Q75248220 | ||
| Interphalangeal osteoarthritis | Q78829067 | ||
| Classification criteria for psoriatic arthritis: development of new criteria from a large international study | Q80001900 | ||
| [Psoriatic arthritis: epidemiological and clinical aspects in a cohort of 1.306 Italian patients] | Q82098837 | ||
| Early psoriatic arthritis | Q84595079 | ||
| Pityriasis lichenoides | Q85747443 | ||
| Early Psoriatic Arthritis | Q86503843 | ||
| Circumscribed juvenile pityriasis rubra pilaris responsive to alitretinoin | Q86668114 | ||
| Diagnosis and management of psoriatic arthritis | Q87306640 | ||
| Psoriatic arthritis | Q93745377 | ||
| Diagnosis and treatment of seborrheic dermatitis | Q28086860 | ||
| Acne-pustulosis-hyperostosis-osteitis syndrome. Results of a national survey. 85 cases | Q28285419 | ||
| A sonographic spectrum of psoriatic arthritis: "the five targets". | Q30484480 | ||
| Septic arthritis: immunopathogenesis, experimental models and therapy | Q33597430 | ||
| IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells | Q33990291 | ||
| Apremilast, a cAMP phosphodiesterase-4 inhibitor, demonstrates anti-inflammatory activity in vitro and in a model of psoriasis | Q34091087 | ||
| Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern | Q34135774 | ||
| Characterization of dermal dendritic cells in psoriasis. Autostimulation of T lymphocytes and induction of Th1 type cytokines | Q34234920 | ||
| Clinical and histologic diagnostic guidelines for psoriasis: a critical review | Q34249689 | ||
| Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies | Q34353941 | ||
| Psoriatic arthritis: clinical aspects, genetics, and the role of T cells | Q34368852 | ||
| Ultrasound composite scores for the assessment of inflammatory and structural pathologies in Psoriatic Arthritis (PsASon-Score). | Q34587374 | ||
| Differential diagnosis of psoriasis | Q34610612 | ||
| Malassezia, dandruff and seborrhoeic dermatitis: an overview | Q34632348 | ||
| Association of Psoriatic Disease With Uveitis: A Danish Nationwide Cohort Study | Q34671931 | ||
| Differentiation between osteoarthritis and psoriatic arthritis: implications for pathogenesis and treatment in the biologic therapy era | Q34727681 | ||
| High-resolution MRI assessment of dactylitis in psoriatic arthritis shows flexor tendon pulley and sheath-related enthesitis | Q34818578 | ||
| Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy? | Q34937925 | ||
| The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials | Q34984568 | ||
| Histopathological findings are associated with the clinical types of psoriasis but not with the corresponding lesional psoriasis severity index | Q35069935 | ||
| Cumulative inflammatory burden is independently associated with increased arterial stiffness in patients with psoriatic arthritis: a prospective study. | Q35257745 | ||
| Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis? | Q35547733 | ||
| Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment | Q35638455 | ||
| Apremilast, a novel phosphodiesterase 4 (PDE4) inhibitor, regulates inflammation through multiple cAMP downstream effectors. | Q36061710 | ||
| The Epidemiology of Psoriatic Arthritis | Q36175115 | ||
| Axial disease in psoriatic arthritis | Q37051508 | ||
| Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues | Q37299354 | ||
| The use of TNF-α blockers in psoriatic arthritis patients with latent tuberculosis infection | Q37655910 | ||
| Diagnosis and classification in spondyloarthritis: identifying a chameleon | Q37997305 | ||
| Psoriatic arthritis: imaging techniques | Q38018074 | ||
| Osteoporosis and psoriatic arthritis. | Q38023168 | ||
| Differential diagnosis of rheumatoid and psoriatic arthritis at an early stage in the small hand and foot joints using magnetic resonance imaging | Q38029540 | ||
| Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis | Q38118781 | ||
| Interleukin 17A: toward a new understanding of psoriasis pathogenesis | Q38198216 | ||
| GRAPPA treatment recommendations: an update from the GRAPPA 2013 Annual Meeting | Q38216633 | ||
| Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study | Q59781603 | ||
| Transcriptional network profile on synovial fluid T cells in psoriatic arthritis | Q61649466 | ||
| JAK/STAT/PKCδ molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis | Q61649471 | ||
| Blockade of intra-articular TNF in peripheral spondyloarthritis: Its relevance to clinical scores, quantitative imaging and synovial fluid and synovial tissue biomarkers | Q61649482 | ||
| Psoriatic arthritis and TNF inhibitors: advances on effectiveness and toxicity | Q61824538 | ||
| Psoriatic arthritis: advances in pharmacotherapy based on molecular target | Q61824570 | ||
| New Developments in Magnetic Resonance Imaging of the Nail Unit | Q61824575 | ||
| Screening and Monitoring of Latent Tubercular Infection in Patients Taking Tumor Necrosis Factor- Blockers for Psoriatic Arthritis | Q61824577 | ||
| Alitretinoin (9-cis retinoic acid) is effective against pityriasis rubra pilaris: a retrospective clinical study | Q64050201 | ||
| The clinical spectrum of psoriatic spondylitis | Q68093280 | ||
| Psoriatic arthritis (PSA)--an analysis of 220 patients | Q69409096 | ||
| Synovitis-acne-pustulosis hyperostosis-osteomyelitis syndrome (SAPHO). A new syndrome among the spondyloarthropathies? | Q70062955 | ||
| Psoriatic arthritis in psoriatic patients | Q70640451 | ||
| Pityriasis rubra pilaris | Q71263523 | ||
| Ankylosing Spondylitis and Spondylitis Accompanying Ulcerative Colitis, Regional Enteritis, Psoriasis and Reiter's Disease. A Comparative Study | Q71800414 | ||
| Erosive osteoarthritis and the main en lorgnette deformity (opera glass hand) | Q71807985 | ||
| Ankylosis in osteoarthritis of the finger joints | Q71815862 | ||
| Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin disease | Q72177619 | ||
| Erosive osteoarthritis of the hands | Q72850183 | ||
| Advances in the management of psoriatic arthritis | Q38227264 | ||
| Pityriasis rosea of Gibert: immunological aspects | Q38247090 | ||
| The JAK-STAT pathway: impact on human disease and therapeutic intervention | Q38317993 | ||
| Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection | Q38344512 | ||
| EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. | Q38402703 | ||
| Interleukin-17 and innate immunity in infections and chronic inflammation | Q38496581 | ||
| Psoriasis inversa: A separate identity or a variant of psoriasis vulgaris? | Q38519134 | ||
| Psoriatic Arthritis Mutilans: Clinical and Radiographic Criteria. A Systematic Review. | Q38528421 | ||
| Clinical Features and Diagnostic Considerations in Psoriatic Arthritis | Q38609814 | ||
| Imaging in Psoriatic Arthritis | Q38609820 | ||
| The Definition and Measurement of Axial Psoriatic Arthritis. | Q38622059 | ||
| Role of Agents other than Tumor Necrosis Factor Blockers in the Treatment of Psoriatic Arthritis | Q38622088 | ||
| Progress in understanding and utilizing TNF-α inhibition for the treatment of psoriatic arthritis. | Q38630548 | ||
| Emerging drugs for psoriatic arthritis | Q38710642 | ||
| Psoriatic arthritis. Clinical manifestations | Q40697394 | ||
| Fragility Fractures in Patients with Psoriatic Arthritis. | Q41160242 | ||
| Simple clinical indicators for early psoriatic arthritis detection. | Q41446342 | ||
| Pityriasis rosea like drug rash - a need to identify the disease in childhood | Q42077643 | ||
| Intertrigo and secondary skin infections | Q42220879 | ||
| Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients | Q42274394 | ||
| Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint. | Q42420342 | ||
| Identification of the clinical features distinguishing psoriatic arthritis and fibromyalgia | Q42632287 | ||
| Apremilast, a novel PDE4 inhibitor, inhibits spontaneous production of tumour necrosis factor-alpha from human rheumatoid synovial cells and ameliorates experimental arthritis | Q42663487 | ||
| Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study | Q43727420 | ||
| The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study | Q43955638 | ||
| Narrowband UVB phototherapy for pediatric generalized pityriasis lichenoides. | Q44103322 | ||
| Are anti-CCP antibodies in psoriatic arthritis patients a biomarker of erosive disease? | Q44490496 | ||
| Psoriatic arthritis mutilans (PAM) in the Nordic countries: demographics and disease status. The Nordic PAM study. | Q45841874 | ||
| Health-related quality of life and disability in patients with rheumatoid, early rheumatoid and early psoriatic arthritis treated with etanercept | Q48842622 | ||
| Psoriatic Arthritis Mutilans: Characteristics and Natural Radiographic History. | Q50913225 | ||
| Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis. | Q51658693 | ||
| Erythrodermic pityriasis rubra pilaris: Dramatic response to infliximab therapy. | Q53221124 | ||
| Is narrowband ultraviolet B monotherapy effective in the treatment of pityriasis lichenoides? | Q53325401 | ||
| [Pityriasis Lichenoides: Case report and review of the literature]. | Q53397640 | ||
| Ex Vivo Signaling Protein Mapping in T Lymphocytes in the Psoriatic Arthritis Joints. | Q53455402 | ||
| Differentiation of pityriasis lichenoides chronica from guttate psoriasis by dermoscopy. | Q53616234 | ||
| Insulin resistance and skin diseases. | Q53843026 | ||
| P433 | issue | 8 | |
| P921 | main subject | psoriatic arthritis | Q511097 |
| P304 | page(s) | 1893-1901 | |
| P577 | publication date | 2016-05-07 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Psoriatic arthritis and psoriasis: differential diagnosis | |
| P478 | volume | 35 |
| Q90190144 | A Multimodal Eye Assessment in Psoriatic Arthritis Patients sine-Psoriasis: Evidence for a Potential Association with Systemic Inflammation |
| Q40044596 | Acute generalized exanthematous pustulosis and polyarthritis associated with a novel CARD14 mutation. |
| Q99238557 | An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis |
| Q41491518 | Is there any link between tumor-induced osteomalacia and psoriasis? A case report |
| Q50127587 | Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study. |
| Q88205381 | Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study |
| Q64231005 | Patient Perspective on the Burden of Skin and Joint Symptoms of Psoriatic Arthritis: Results of a Multi-National Patient Survey |
| Q64108411 | Psoriasis Features in Patients with Inflammatory Bowel Disease |
| Q92175170 | Psoriatic arthritis - new perspectives |
| Q88336737 | Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules" |
| Q90440408 | Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting |
| Q33454808 | The effect of smartphone addiction on hand joints in psoriatic patients: an ultrasound-based study |
| Q33841808 | Vitamin D and its role in psoriasis: An overview of the dermatologist and nutritionist. |
Search more.